The collaboration is a Canadian-CIRM project (see item below) and is aimed at funding disease teams that will bring "an investigational new drug filing at the end of the four‐to‐five year grant."
Canadian registration is required by Monday Nov. 17.
The Canadians want the names of the PIs in both Canada and California and the following information:
"the scientifically mature opportunity, with strong preclinical proof-of-concept, to use cancer stem cells in the development of a therapy or diagnosticHere is a link to the registration document. Sphere: Related Content
"key milestones and deliverables required to achieve the objectives envisaged
"the nature of the partnership between the Canadian and Californian participants
"any anticipated commercial partnerships"